JBA AI Earns FDA SaMD Recognition
A New Era of Accessible Health Monitoring
GARDEN GROVE, CALIFORNIA / ACCESS Newswire / June 9, 2025 / JBA AI, the flagship health-tech division under AQ Pharmaceuticals, Inc. and JBA Brands, proudly announces several major global milestones in its mission to make preventive healthcare more accessible, intelligent, and affordable.JBA AI Infographic
JBA AI has been officially recognized by the United States Food and Drug Administration (FDA) as a Software as a Medical Device (SaMD). In addition, the platform has now received Class B Medical Device approval from Vietnam's Ministry of Health. These achievements affirm the platform's safety, clinical effectiveness, and international credibility.
The JBA AI mobile application is already available globally for Android users and will soon be released on iOS. It enables contactless, non-invasive vital signs monitoring directly through smartphones or tablets. In just 60 seconds, the app delivers insights on over nine key health metrics. These include heart rate, heart rate variability, blood oxygen saturation, respiratory rate, stress index, and estimated glucose and blood pressure trends. This is achieved using AI-powered facial signal analysis through camera-based remote photoplethysmography technology.
Expanding its impact even further, JBA AI has partnered with one of Vietnam's largest financial institutions, which serves more than 30 millions members. Together, they are preparing to launch JBA AI nationwide, making preventive health monitoring more accessible through a trusted and widespread digital network.
'JBA AI is more than a health app - it's a certified medical device. Recognized by both the FDA and Vietnam's Ministry of Health,' said Tracy Trang Nguyen, founder and CEO of JBA AI. 'We're proud to deliver trusted, clinically guided tools for daily health monitoring worldwide.'
Nguyen is a Vietnamese American engineer and wellness industry leader who developed JBA AI after surviving cancer. Her personal health journey inspired her to combine advanced artificial intelligence with affordable wellness solutions. Under her leadership, JBA AI complements other products within the JBA Brands portfolio, such as GlucoTrojan, Joint Revive Fucoidan, and Vegan Collagen, to form a fully integrated health ecosystem.
JBA AI is already gaining traction and is starting to expand into pharmacies, corporate wellness programs, public health campaigns, and family clinics across the United States, Vietnam, and other countries. The platform's franchise-ready model supports rapid local deployment while keeping costs low and impact high. It is designed to help people monitor their health in real-time, without the need for needles, wearable devices or clinic visits.
JBA AI is currently welcoming franchisees, affiliates, and institutional partners to help bring this technology to communities around the world. Whether at home or in partnership with healthcare providers, JBA AI is redefining preventive care through data-driven technology and a compassionate approach to well-being.
Contact Information
Catherine Marino
Marketing Manager
[email protected]
(+1) 714 903 1009
SOURCE: AQP One, Inc.
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
Digital Natives vs Seasoned Docs: Who's Adopting AI Faster?
Up until very recently, when Jeremy Lipman, MD, met with patients, he had an invisible tether to his computer due to the need to document each visit. But in the past few months, he has experienced a new sense of professional freedom. Now an artificial intelligence (AI) scribe platform documents the conversation during each visit, allowing him to focus more fully on the patient in front of him. 'I'm not at the computer when I'm with the patient anymore,' Lipman told Medscape Medical News . 'The phone sits on the desk. I am away from the desk, sitting right in front of the patient…just having a conversation.' 'The software is absolutely remarkable,' he said about Ambience Healthcare's new AI documentation platform that Cleveland Clinic recently launched throughout its health system. Lipman is a colorectal surgeon at the clinic and has been in practice since 2010. While he's admittedly not an expert on the differences in how early-career physicians adopt and utilize technology as compared to more experienced physicians, Lipman said older doctors seem to be embracing it, too. 'I'm often surprised when we talk about a technology that sometimes some of the older doctors will tell you, 'I've been using that and I love it,'' Lipman said. The AI scribe platform listens to the interaction between the healthcare provider and the patient and 'captures the transcript of the conversation,' explained Lisa Stump, chief digital information officer at Mount Sinai Health System, New York City. Next, the platform transforms the transcript into the doctor's note. Physicians then need to review and sign off on the note, Lipman said. In addition to Ambience, there are a number of other AI scribe platforms, such as Abridge, Nuance DAX and Suki, Stump said, and they are really taking off. It's not just AI scribe technologies that are altering the medical landscape. Other tech innovations that are changing things are: AI-driven diagnostics, mobile health apps, and wearable devices monitoring a patients' health in real time. Are doctors of all ages embracing these new and evolving technologies in the same way? Medscape Medical News reached out to variety of experts to get their take. Embracing Digital Innovation 'While there is variability in awareness and depth of understanding, there is consistent enthusiasm for technology,' Cleveland Clinic's Chief Digital Officer Rohit Chandra, PhD, said in an email. 'And — what is more — senior leaders across the organization (who tend to be more experienced doctors) are proactive about driving and supporting technology initiatives where they see potential.' From Stump's perspective, those who grew up as 'digital natives' are 'I think more readily able to interact with a variety of different digital interfaces,' she said. While it's not always the case, older generations tend to be more skeptical and hesitant — at least initially. They also want to understand the safety and liability of the technology and make sure it won't disrupt workflow, Stump said. There are differences in technology acceptance, assessment, and adoption between generations, said Clark Otley, MD, a dermatologic oncologist and chief medical officer for Mayo Clinic Platform, which he describes as a 'privacy protected, innovation inducing platform that brings in partners from all over the world to develop new technologies.' 'Obviously, you're going to have a lot of variation within a specific generation, as well as between generations,' said Otley. 'On average, maybe the earlier generations might be a little bit more cautious and a little less facile at accepting and adopting technology.' Sometimes, older doctors will even retire at the beginning of a technology rollout, he said. But as a society, we can't afford that, as it would 'exacerbate the shortage of healthcare workers,' Otley said. Therefore, healthcare organizations have a responsibility to create an environment in which all providers can succeed in adopting digital healthcare technology, according to Otley. When introducing new technologies, medical institutions should offer multi-modal training, Otley said. There's a science behind it, he said, and it's true of every generation. Some people are visual learners, while others are auditory or experiential learners, so there needs to be a variety of types of training. The institution should also recognize and support different generations in terms of learning, Otley said. For example, older generations tend to value face-to-face teaching and learning more than digital or remote learning, Otley said. So having access to 'super users' — peers who delve deeply into the technology early on and learn it well — can also be helpful to them. It's also not enough for organizations to provide one 30-minute training session without a follow-up, he said. Intergenerational teams are important, too, said Otley, who is 60 years old. 'The magic happens when the older generation teaches the younger generation wisdom, and the younger generation brings the older generation up now with technology, and that middle generation is in their, maybe 'sweet spot' of raw cognitive power and digital capabilities,' he said. 'So for me, the combination is the best thing in healthcare.' How Far We've Come In the past 10 years, the growth in technology and digital health has been 'dramatic,' Lipman said. When he started as an attending doctor, 'we were still doing some paper charting. We were doing some paper ordering. I mean, that's unheard of today.' Ten years ago, 'digital tools and technology and healthcare were really transactional systems,' said Stump. 'People entered data, ran reported. It was all very human driven.' 'I would say the biggest impact we're now seeing by automating a lot of that work, we're reducing the cognitive burden, the administrative burden…[which has been the biggest physician complaint since implementing electronic medical records],' Stump said. Today, when Lipman has a medical question, 'the resources that are available from online sources — GPT, other resources like GPT that use large language models —[have] been fantastic,' he said. 'This AI thing is another just tremendous leap forward.' It's clear that these new technologies are being utilized more and more in the healthcare landscape. 'I think it varies by organization to some degree,' Stump said about the current lay of the land in this realm, 'but generally speaking, the COVID pandemic definitely accelerated the adoption of digital health technologies, right? Out of necessity and literally overnight, large health systems and small had to figure out how to provide care not in the traditional face-to-face, in person manner.' The pandemic accelerated the adoption of telehealth, which peaked, waned, and has now plateaued, Stump said. 'With now the rapid growth of artificial intelligence and agentic AI solutions, I think we're seeing another uptick in the development of new solutions and their adoption,' she said. Agentic AI exists when the AI model not only looks at the historical data and draws a conclusion, but 'it can then take action,' said Stump. Additionally, there are 'very well-established' remote patient monitoring programs for patients with diabetes and hypertension who use wearables at home, 'and these data are being captured and monitored either by an AI solution with a human then responding to an alert or always monitored by a human,' Stump said. The Future of AI in Medicine 'I think that helping people find really good evidence to support the decisions they have to make — and [them] being more engaged in their own health — is coming,' Lipman said. '…Perhaps even as we're talking and the AI is understanding what we're talking about, that an evidence-based treatment plan becomes part of the note that gets generated right away, so that then the patient and I can look at that together and talk about what that means,' he said. The 'downstream ability to code the record automatically and accurately is really starting to make a huge impact,' Stump said. 'I am very cautiously optimistic about the role of AI and the technology.' But Stump said it's important to have a rigorous approach up front as we 'evaluate technologies before we deploy them at scale and then continually monitor them as they are in use to be sure the models don't shift or change in a way that creates unintended consequences.' Lipman's advice is that physicians always need to be the final check. 'Trust, but verify,' he said. 'These things provide a great pathway to getting information, but it still needs to be verified as accurate.'
Business Wire
2 hours ago
- Business Wire
CoreCare Achieves SOC 2 Compliance, Reinforcing Commitment to Deliver Secure, Trustworthy AI for Post-Acute and Long-Term Care Providers
NEW YORK--(BUSINESS WIRE)-- CoreCare, the leading AI-powered workflow platform for post-acute and long-term care (PALTC) providers, today announced it has successfully completed its SOC 2 audit, affirming the company's rigorous commitment to data security and operational excellence. CoreCare has successfully completed its SOC 2 audit, affirming the company's rigorous commitment to data security and operational excellence. Share 'Securing sensitive data isn't optional, especially in healthcare,' said Mehrdad Shafaie, Co-Founder & COO of CoreCare. 'This audit reflects the discipline and integrity we bring to every part of the platform. For SNF operators, trusting an AI vendor starts with security, and we take that responsibility seriously.' Developed by the American Institute of Certified Public Accountants (AICPA), SOC 2 is an industry-recognized standard for data handling practices based on five 'trust service principles': security, availability, processing integrity, confidentiality, and privacy. CoreCare's audit was conducted by Advantage Partners, with automation support from Vanta, a leading compliance automation platform. The successful completion of the SOC 2 assessment confirms that CoreCare has implemented effective internal controls to safeguard client data - an essential requirement for healthcare providers navigating regulatory complexity and HIPAA compliance. This achievement reinforces CoreCare's mission to help providers harness the power of AI with confidence, compliance and trust. About CoreCare CoreCare is the leading AI-powered workflow platform built specifically for post-acute and long-term care providers. Trusted by thousands of skilled nursing facilities nationwide, CoreCare's Collaborative Revenue Management platform replaces spreadsheets, manual reviews, and disconnected portals with technology that enables expert-level decisions and teamwork at every step of the revenue cycle. Backed by Y Combinator and leading health tech investors, CoreCare is building the infrastructure for AI-powered healthcare operations. To learn more about CoreCare, visit and connect with us on LinkedIn.
Business Wire
3 hours ago
- Business Wire
UCP Merchant Medicine Names Chris Lukasiak as New CEO
MINNEAPOLIS--(BUSINESS WIRE)--UCP Merchant Medicine, the leading provider of consulting services and AI technology for the Urgent Care sector of healthcare, announced today Chris Lukasiak has joined the company as Chief Executive Officer. Mr. Lukasiak is responsible for shaping the vision and strategy of UCP Merchant Medicine and accelerating the development and deployment of Intellivisit, the company's Artificial Intelligence (AI)-based clinical decision and efficiency support tool designed for urgent care centers. "As we accelerate growth and scale the business, there is no better person to lead UCP Merchant Medicine than Chris," said Jay Mason, Chairman of the Board of Directors. "I've known Chris for more than 10 years, and he has an outstanding track record of success, along with a strong combination of vision, industry insight, and ability to bring people together. A seasoned innovator and an executive with a proven ability to scale, Chris has what it takes to build upon and expand UCP Merchant Medicine's market leadership position." A 25-year healthcare industry veteran, Lukasiak brings a broad range of strategic and operational experiences from industry leaders in the telehealth, population health, digital front door, and electronic medical record healthcare industries. He joins UCP Merchant Medicine from Access TeleCare, the national leader in inpatient telehealth. "I'm excited to join UCP Merchant Medicine in its 10 th year, at this exciting time in the company's growth, as we are poised to lead the innovation of healthcare delivery,' said Chris Lukasiak, CEO of UCP Merchant Medicine. 'Our foundation is incredibly strong; with more than 3 million patient visits per year, we deliver an average NPS score of 94 and an average door-to-door time of 34 minutes in urgent care. That industry leadership is a result of our team's passion for – and commitment to – transforming healthcare delivery, reducing costs for patients and the delivery system, improving access and health equity, and bringing the kind of care we each desire for our loved ones. The next chapter of UCP Merchant Medicine will further solidify the company's position as a leader in efficient, patient-centric and profitable healthcare delivery.' UCP Merchant Medicine currently serves 71 health systems across the U.S. With the company's AI-based clinical solutions, systems break-even financially with just 16 urgent care patients a day, compared to the industry average of 43. 'We are facing an exciting inflection point for healthcare operators who combine process redesign with the benefits of artificial intelligence,' said Brandon Robertson, Founder and President of UCP Merchant Medicine and Intellivisit Solutions. 'The first ten years of UCP Merchant Medicine were focused on building a strong foundation—refining operational models, standardizing high-quality urgent care delivery, and proving that our clinical operations can consistently outperform national benchmarks. With the addition of Chris, who brings exceptional leadership and complementary expertise, we are now able to amplify our impact—expanding Modern Urgent Care across diverse health systems and embedding AI Decision Support into all frontline clinical workflows. Together, we will help urgent care centers lead the transformation of ambulatory care and extend innovation across the broader healthcare ecosystem.' About UCP Merchant Medicine and Intellivisit Solutions UCP Merchant Medicine is the backbone behind some of the most successful urgent care platforms in the country. We partner with health systems and operators to build urgent care that works the way it should—lean, fast, and clinically precise at scale. Our strategic advisory services reshape front-end care delivery, integrating operational redesign with real-time clinical execution. The result: platforms that are easier to staff, simpler to manage, and consistently deliver high performance. Across 3 million+ annual visits, our model achieves an average 94 net promoter score and half the industry average financial breakeven at only 16 visits per day, with average door-to-door times of 34 minutes. At the center is Intellivisit Concierge—our clinical intelligence platform. More than decision support, it re-engineers intake, sharpens provider thinking, and ensures every patient encounter is aligned to clinical Standard Operating Procedures. Built on 40,000+ hours of physician-led development, it delivers structured, actionable insight—before the provider even walks into the room. Learn more at
